The Pharmaceutical Research and Manufacturers of America is sponsoring a new mobile health screening program next year to address chronic disease in New York City.
Hikma and Vectura plan to develop generic versions of GSK's Ellipta portfolio, utilizing Vectura's proprietary "open-inhale-close" dry powder inhaler device.
Drug Store News has partnered with CE Impact to offer our readers free access to two on-demand CE courses focused on vaccinations — click through to claim the code.